Analysed PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) News Sources
Palvella Therapeutics Submits First Module of Rolling New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
29-06-2026
yahoo.com
Palvella Therapeutics Chief Scientific Officer Jeff Martini, Ph.D. Selected to Present at Upcoming FDA Public Workshop on Drug Repurposing
30-07-2026
yahoo.com
Palvella Therapeutics Eyes 2027 QTORIN Approval as Rare-Disease Pipeline Expands
16-08-2026
marketbeat.com
Palvella Therapeutics Completes Rolling Submission of New Drug Application to FDA for QTORIN™ Rapamycin for the Treatment of Microcystic Lymphatic Malformations
31-08-2026
yahoo.com
Palvella Therapeutics Appoints James R. Treat, M.D., Nationally Recognized Pediatric Dermatologist as Chief Medical Officer
09-09-2026
yahoo.com
What is the current price of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?
The current price of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is $138.77.
PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) absolute price change since previous trading day?
The absolute price change of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) since the previous trading day is $7.43.
PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) percentage price change since previous trading day?
The percentage price change of PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) since the previous trading day is 5.6571%.
What is the most recent average sentiment score for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?
The most recent average sentiment score for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is 82 out of 100.
What is the most recent average sentiment for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)?
The most recent sentiment for PALVELLA THERAPEUTICS INC (PVLA:NASDAQ) is .
SEC-8K** Filing Available For PALVELLA THERAPEUTICS INC (PVLA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.